中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 39 Issue 7
Jul.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2023  >  39(7): 1643-1656

Influencing factors for acute necrotizing pancreatitis in Eastern and Western countries: A meta-analysis

DOI: 10.3969/j.issn.1001-5256.2023.07.019
  • 1.

    Department of Gastroenterology, Subei People's Hospital, Yangzhou, Jiangsu 225000, China

  • 2.

    Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226000, China

  • 3.

    School of Nursing, Yangzhou University, Yangzhou, Jiangsu 225000, China

  • 4.

    Department of Gastroenterology, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu 225000, China

Research funding:

National Natural Science Foundation (82004291);

Natural Science Foundation of Jiangsu Province (BK20190907);

Six Talent Peaks Project of Jiangsu Province (WSN-325)

More Information
  • Corresponding author: CHEN Juan, chenjuan406512@163.com (ORCID: 0000-0002-2181-2636)
  • Received Date: 2022-03-18
  • Accepted Date: 2022-04-24
  • Published Date: 2023-07-20
    Abstract
  •   Objective  To investigate the differences in the influencing factors for acute necrotizing pancreatitis (ANP) and infectious pancreatic necrosis (IPN) between Eastern and Western countries, and to provide a theoretical basis for the prediction and prevention of ANP.  Methods  Databases including PubMed, Embase, the Cochrane Library, and Web of Science were searched for articles on the influencing factors for ANP and IPN published up to January 21, 2021, and a Meta-analysis was performed.  Results  A total of 59 studies were included, with 22 studies from Eastern countries and 37 studies from Western countries.The Meta-analysis showed that in Eastern countries, male sex (odds ratio[OR]=1.51, 95% confidence interval[CI]: 1.18-1.91, P < 0.01), C-reactive protein (CRP)(standardized mean difference[SMD]=1.39, 95%CI: 1.06-1.71, P < 0.01), D-dimer (SMD=0.44, 95%CI: 0.07-0.81, P=0.02), Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE-Ⅱ) score (mean difference[MD]=3.51, 95%CI: 1.38-5.64, P < 0.01), alcoholic etiology (OR=3.57, 95%CI: 2.68-4.75, P < 0.01), and biliary etiology (OR=0.60, 95%CI: 0.46-0.77, P < 0.01) were the influencing factors for ANP, and in Western countries, male sex (OR=1.63, 95%CI: 1.30-2.05, P < 0.01), CRP (SMD=2.09, 95%CI: 1.12-3.05, P < 0.01), APACHE-Ⅱ score (MD=4.28, 95%CI: 2.73-5.83, P < 0.01), Ranson score (MD=2.99, 95%CI: 2.50-3.47, P < 0.01), and organ failure (OR=10.87, 95%CI: 2.62-45.04, P < 0.01) were the influencing factors for ANP.In Eastern countries, age (MD=2.16, 95%CI: 0.43-3.89, P=0.01), body mass index (BMI)(MD=1.74, 95%CI: 1.23-2.25, P < 0.01), albumin level (SMD=-0.43, 95%CI: -0.75 to-0.12, P < 0.01), CRP (SMD=0.58, 95%CI: 0.04-1.11, P=0.03), procalcitonin (SMD=0.80, 95%CI: 0.56-1.04, P < 0.01), D-dimer (MD=0.23, 95%CI: 0.15-0.31, P < 0.01), APACHE-Ⅱ score (MD=2.47, 95%CI: 0.73-4.22, P < 0.01), Ranson score (MD=1.60, 95%CI: 1.46-1.73, P < 0.01), and extent of necrosis ≥30%(OR=2.52, 95%CI: 1.26-5.06, P < 0.01) were the influencing factors for IPN, while in Western countries, age (MD=4.07, 95%CI: 1.82-6.31, P < 0.01), APACHE-Ⅱ score (MD=3.28, 95%CI: 1.39-5.17, P < 0.01), Ranson score (MD=2.18, 95%CI: 1.75-2.62, P < 0.01), SIRS score (OR=3.88, 95%CI: 1.58-9.51, P < 0.01), alcoholic etiology (OR=0.61, 95%CI: 0.42-0.87, P < 0.01), and organ failure (OR=3.63, 95%CI: 1.11-11.92, P=0.03) were the influencing factors for IPN.  Conclusion  Current evidence shows that biliary etiology and alcoholic etiology are unique influencing factors for ANP in the Eastern population, while Ranson score is a unique influencing factor in the Western population.BMI and extent of necrosis ≥30% are unique influencing factors for IPN in the Eastern population, while alcoholic etiology is a unique influencing factor in the Western population.

     

    • FullText(HTML)
  • loading
    • References(89)
  • [1]
    TAN C, YANG L, SHI F, et al. Early systemic inflammatory response syndrome duration predicts infected pancreatic necrosis[J]. J Gastrointest Surg, 2020, 24(3): 590-597. DOI: 10.1007/s11605-019-04149-5.
    [2]
    MEDEROS MA, REBER HA, GIRGIS MD. Acute pancreatitis:A review[J]. JAMA, 2021, 325 (4):382-390. DOI:10. 1001/JAMA. 2020. 20317
    [3]
    BARON TH, DIMAIO CJ, WANG AY, et al. American Gastroenterological Association Clinical Practice Update: Management of pancreatic necrosis[J]. Gastroenterology, 2020, 158(1): 67-75. e1. DOI: 10.1053/j.gastro.2019.07.064.
    [4]
    DING L, YU C, DENG F, et al. New Risk factors for infected pancreatic necrosis secondary to severe acute pancreatitis: The role of initial contrast-enhanced computed tomography[J]. Dig Dis Sci, 2019, 64(2): 553-560. DOI: 10.1007/s10620-018-5359-y.
    [5]
    TRIKUDANATHAN G, WOLBRINK D, van SANTVOORT HC, et al. Current concepts in severe acute and necrotizing pancreatitis: An evidence-based approach[J]. Gastroenterology, 2019, 156(7): 1994-2007. e3. DOI: 10.1053/j.gastro.2019.01.269.
    [6]
    MAK WY, ZHAO M, NG SC, et al. The epidemiology of inflammatory bowel disease: East meets west[J]. J Gastroenterol Hepatol, 2020, 35(3): 380-389. DOI: 10.1111/jgh.14872.
    [7]
    HOZO SP, DJULBEGOVIC B, HOZO I. Estimating the mean and variance from the median, range, and the size of a sample[J]. BMC Med Res Methodol, 2005, 5: 13. DOI: 10.1186/1471-2288-5-13.
    [8]
    WAN X, WANG W, LIU J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range[J]. BMC Med Res Methodol, 2014, 14: 135. DOI: 10.1186/1471-2288-14-135.
    [9]
    MAO J, ZHANG Q, ZHANG H, et al. Risk factors for lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis[J]. Front Endocrinol (Lausanne), 2020, 11: 265. DOI: 10.3389/fendo.2020.00265.
    [10]
    JI X, LENG XY, DONG Y, et al. Modifiable risk factors for carotid atherosclerosis: a meta-analysis and systematic review[J]. Ann Transl Med, 2019, 7(22): 632. DOI: 10.21037/atm.2019.10.115.
    [11]
    VAN DER VLIST AC, BREDA SJ, OEI E, et al. Clinical risk factors for Achilles tendinopathy: a systematic review[J]. Br J Sports Med, 2019, 53(21): 1352-1361. DOI: 10.1136/bjsports-2018-099991.
    [12]
    KUNZE KN, WRIGHT-CHISEM J, POLCE EM, et al. Risk factors for ramp lesions of the medial meniscus: A systematic review and meta-analysis[J]. Am J Sports Med, 2021, 49(13): 3749-3757. DOI: 10.1177/0363546520986817.
    [13]
    BVCHLER M, MALFERTHEINER P, SCHOETENSACK C, et al. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study[J]. Int J Pancreatol, 1986, 1(3-4): 227-235. DOI: 10.1007/BF02795248.
    [14]
    BVCHLER M, MALFERTHEINER P, SCHÄDLICH H, et al. Prognostic value of serum phospholipase A in acute pancreatitis[J]. Klin Wochenschr, 1989, 67(3): 186-189. DOI: 10.1007/BF01711351.
    [15]
    DOMSCHKE S, MALFERTHEINER P, UHL W, et al. Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis[J]. Int J Pancreatol, 1993, 13(2): 105-110. DOI: 10.1007/BF02786078.
    [16]
    KAUFMANN P, TILZ GP, SMOLLE KH, et al. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis[J]. Immunobiology, 1996, 195(2): 209-219. DOI: 10.1016/S0171-2985(96)80040-4.
    [17]
    SCHMID SW, UHL W, STEINLE A, et al. Human pancreas-specific protein. A diagnostic and prognostic marker in acute pancreatitis and pancreas transplantation[J]. Int J Pancreatol, 1996, 19(3): 165-170. DOI: 10.1007/BF02787364.
    [18]
    MANES G, SPADA OA, RABITTI PG, et al. Serum interleukin-6 in acute pancreatitis due to common bile duct stones. A reliable marker of necrosis[J]. Recenti Prog Med, 1997, 88(2): 69-72.
    [19]
    RAU B, STEINBACH G, GANSAUGE F, et al. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis[J]. Gut, 1997, 41(6): 832-840. DOI: 10.1136/gut.41.6.832.
    [20]
    TENNER S, SICA G, HUGHES M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis[J]. Gastroenterology, 1997, 113(3): 899-903. DOI: 10.1016/s0016-5085(97)70185-9.
    [21]
    BAILLARGEON JD, ORAV J, RAMAGOPAL V, et al. Hemoconcentration as an early risk factor for necrotizing pancreatitis[J]. Am J Gastroenterol, 1998, 93(11): 2130-2134. DOI: 10.1111/j.1572-0241.1998.00608.x.
    [22]
    RAU B, CEBULLA M, UHL W, et al. The clinical value of human pancreas-specific protein procarboxypeptidase B as an indicator of necrosis in acute pancreatitis: comparison to CRP and LDH[J]. Pancreas, 1998, 17(2): 134-139. DOI: 10.1097/00006676-199808000-00004.
    [23]
    HIETARANTA A, KEMPPAINEN E, PUOLAKKAINEN P, et al. Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis[J]. Pancreas, 1999, 18(4): 385-391. DOI: 10.1097/00006676-199905000-00009.
    [24]
    BROWN A, ORAV J, BANKS PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis[J]. Pancreas, 2000, 20(4): 367-372. DOI: 10.1097/00006676-200005000-00005.
    [25]
    BUTTENSCHOEN K, BERGER D, HIKI N, et al. Endotoxin and antiendotoxin antibodies in patients with acute pancreatitis[J]. Eur J Surg, 2000, 166(6): 459-466. DOI: 10.1080/110241500750008772.
    [26]
    MÁNDI Y, FARKAS G, TAKÁCS T, et al. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis[J]. Int J Pancreatol, 2000, 28(1): 41-49. DOI: 10.1385/IJGC:28:1:41.
    [27]
    MVLLER CA, UHL W, PRINTZEN G, et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis[J]. Gut, 2000, 46(2): 233-238. DOI: 10.1136/gut.46.2.233.
    [28]
    RAU B, STEINBACH G, BAUMGART K, et al. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant[J]. Crit Care Med, 2000, 28(3): 736-742. DOI: 10.1097/00003246-200003000-00022.
    [29]
    RAU B, STEINBACH G, BAUMGART K, et al. The clinical value of procalcitonin in the prediction of infected necrosis in acute pancreatitis[J]. Intensive Care Med, 2000, 26 (Suppl 2): S159-164. DOI: 10.1007/BF02900730.
    [30]
    KHAN AA, PAREKH D, CHO Y, et al. Improved prediction of outcome in patients with severe acute pancreatitis by the APACHE Ⅱ score at 48 hours after hospital admission compared with the APACHE Ⅱ score at admission. Acute Physiology and Chronic Health Evaluation[J]. Arch Surg, 2002, 137(10): 1136-1140. DOI: 10.1001/archsurg.137.10.1136.
    [31]
    MVLLER CA, APPELROS S, UHL W, et al. Serum levels of procarboxypeptidase B and its activation peptide in patients with acute pancreatitis and non-pancreatic diseases[J]. Gut, 2002, 51(2): 229-235. DOI: 10.1136/gut.51.2.229.
    [32]
    PEREZ A, WHANG EE, BROOKS DC, et al. Is severity of necrotizing pancreatitis increased in extended necrosis and infected necrosis?[J]. Pancreas, 2002, 25(3): 229- 233. DOI: 10.1097/00006676-200210000-00003.
    [33]
    RICHÉ FC, CHOLLEY BP, LAISNÉ MJ, et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis[J]. Surgery, 2003, 133(3): 257-262. DOI: 10.1067/msy.2003.70.
    [34]
    BARAUSKAS G, SVAGZDYS S, MALECKAS A. C-reactive protein in early prediction of pancreatic necrosis[J]. Medicina (Kaunas), 2004, 40(2): 135-140.
    [35]
    PAPACHRISTOU GI, PAPACHRISTOU DJ, MORINVILLE VD, et al. Chronic alcohol consumption is a major risk factor for pancreatic necrosis in acute pancreatitis[J]. Am J Gastroenterol, 2006, 101(11): 2605-2610. DOI: 10.1111/j.1572-0241.2006.00795.x.
    [36]
    DAMBRAUSKAS Z, GULBINAS A, PUNDZIUS J, et al. Value of routine clinical tests in predicting the development of infected pancreatic necrosis in severe acute pancreatitis[J]. Scand J Gastroenterol, 2007, 42(10): 1256-1264. DOI: 10.1080/00365520701391613.
    [37]
    LÓPEZ A, de LA CUEVA L, MARTÍNEZ MJ, et al. Usefulness of technetium-99m hexamethylpropylene amine oxime-labeled leukocyte scintigraphy to detect pancreatic necrosis in patients with acute pancreatitis. Prospective comparison with Ranson, Glasgow and APACHE-Ⅱ scores and serum C-reactive protein[J]. Pancreatology, 2007, 7(5-6): 470-478. DOI: 10.1159/000108964.
    [38]
    MULLER CA, BELYAEV O, VOGESER M, et al. Corticosteroid-binding globulin: a possible early predictor of infection in acute necrotizing pancreatitis[J]. Scand J Gastroenterol, 2007, 42(11): 1354-1361. DOI: 10.1080/00365520701416691.
    [39]
    RAHMAN SH, MENON KV, HOLMFIELD JH, et al. Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis[J]. Ann Surg, 2007, 245(2): 282-289. DOI: 10.1097/01.sla.0000245471.33987.4b.
    [40]
    de CAMPOS T, CERQUEIRA C, KURYURA L, et al. Morbimortality indicators in severe acute pancreatitis[J]. JOP, 2008, 9(6): 690-697.
    [41]
    MUDDANA V, WHITCOMB DC, KHALID A, et al. Elevated serum creatinine as a marker of pancreatic necrosis in acute pancreatitis[J]. Am J Gastroenterol, 2009, 104(1): 164-170. DOI: 10.1038/ajg.2008.66.
    [42]
    LIPINSKI M, RYDZEWSKI A, RYDZEWSKA G. Early changes in serum creatinine level and estimated glomerular filtration rate predict pancreatic necrosis and mortality in acute pancreatitis: Creatinine and eGFR in acute pancreatitis[J]. Pancreatology, 2013, 13(3): 207-211. DOI: 10.1016/j.pan.2013.02.002.
    [43]
    TALUKDAR R, NECHUTOVA H, CLEMENS M, et al. Could rising BUN predict the future development of infected pancreatic necrosis?[J]. Pancreatology, 2013, 13(4): 355-359. DOI: 10.1016/j.pan.2013.05.003.
    [44]
    KOSTIC I, SPASIC M, STOJANOVIC B, et al. Early cytokine profile changes in interstitial and necrotic forms of acute pancreatitis[J]. Serb J Exp Clin Res, 2015, 16(1): 33-37. DOI: 10.1515/sjecr-2015-0005.
    [45]
    EASLER JJ, DE-MADARIA E, NAWAZ H, et al. Patients with sentinel acute pancreatitis of alcoholic etiology are at risk for organ failure and pancreatic necrosis: A dual-center experience[J]. Pancreas, 2016, 45(7): 997-1002. DOI: 10.1097/MPA.0000000000000643.
    [46]
    MORAN RA, JALALY NY, KAMAL A, et al. Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis[J]. Pancreatology, 2016, 16(6): 966-972. DOI: 10.1016/j.pan.2016.10.002.
    [47]
    GARRET C, PÉRON M, REIGNIER J, et al. Risk factors and outcomes of infected pancreatic necrosis: Retrospective cohort of 148 patients admitted to the ICU for acute pancreatitis[J]. United European Gastroenterol J, 2018, 6(6): 910-918. DOI: 10.1177/2050640618764049.
    [48]
    VERDONK RC, STERNBY H, DIMOVA A, et al. Short article: Presence, extent and location of pancreatic necrosis are independent of aetiology in acute pancreatitis[J]. Eur J Gastroenterol Hepatol, 2018, 30(3): 342-345. DOI: 10.1097/MEG.0000000000001053.
    [49]
    SZAKÁCS Z, GEDE N, PÉCSI D, et al. Aging and comorbidities in acute pancreatitis Ⅱ. : A cohort-analysis of 1203 prospectively collected cases[J]. Front Physiol, 2018, 9: 1776. DOI: 10.3389/fphys.2018.01776.
    [50]
    ISOGAI M, YAMAGUCHI A, HORI A, et al. LDH to AST ratio in biliary pancreatitis-a possible indicator of pancreatic necrosis: preliminary results[J]. Am J Gastroenterol, 1998, 93(3): 363-367. DOI: 10.1111/j.1572-0241.1998.00363.x.
    [51]
    METTU SR, WIG JD, KHULLAR M, et al. Efficacy of serum nitric oxide level estimation in assessing the severity of necrotizing pancreatitis[J]. Pancreatology, 2003, 3(6): 506-513; discussion 513-514. DOI: 10.1159/000076021.
    [52]
    GARG PK, MADAN K, PANDE GK, et al. Association of extent and infection of pancreatic necrosis with organ failure and death in acute necrotizing pancreatitis[J]. Clin Gastroenterol Hepatol, 2005, 3(2): 159-166. DOI: 10.1016/s1542-3565(04)00665-2.
    [53]
    GARDNER TB, OLENEC CA, CHERTOFF JD, et al. Hemoconcentration and pancreatic necrosis: further defining the relationship[J]. Pancreas, 2006, 33(2): 169-173. DOI: 10.1097/01.mpa.0000226885.32957.17.
    [54]
    UEDA T, TAKEYAMA Y, YASUDA T, et al. Lactate dehydrogenase-to-lymphocyte ratio for the prediction of infection in acute necrotizing pancreatitis[J]. Pancreas, 2007, 35(4): 378-380. DOI: 10.1097/01.mpa.0000297827.05678.9e.
    [55]
    GUO J, XUE P, YANG XN, et al. Serum matrix metalloproteinase-9 is an early marker of pancreatic necrosis in patients with severe acute pancreatitis[J]. Hepatogastroenterology, 2012, 59(117): 1594-1598. DOI: 10.5754/hge11563.
    [56]
    KE L, NI HB, TONG ZH, et al. D-dimer as a marker of severity in patients with severe acute pancreatitis[J]. J Hepatobiliary Pancreat Sci, 2012, 19(3): 259-265. DOI: 10.1007/s00534-011-0414-5.
    [57]
    LU Z, LIU Y, DONG YH, et al. Soluble triggering receptor expressed on myeloid cells in severe acute pancreatitis: a biological marker of infected necrosis[J]. Intensive Care Med, 2012, 38(1): 69-75. DOI: 10.1007/s00134-011-2369-z.
    [58]
    GUO Q, LI A, XIA Q, et al. The role of organ failure and infection in necrotizing pancreatitis: a prospective study[J]. Ann Surg, 2014, 259(6): 1201-1207. DOI: 10.1097/SLA.0000000000000264.
    [59]
    ERBIS H, ALIOSMANOGLU I, TURKOGLU MA, et al. Evaluating mean platelet volume as a new indicator for confirming the diagnosis of necrotizing pancreatitis[J]. Ann Ital Chir, 2015, 86(2): 132-136.
    [60]
    SHEN X, SUN J, KE L, et al. Reduced lymphocyte count as an early marker for predicting infected pancreatic necrosis[J]. BMC Gastroenterol, 2015, 15: 147. DOI: 10.1186/s12876-015-0375-2.
    [61]
    THANDASSERY RB, YADAV TD, DUTTA U, et al. Hypotension in the first week of acute pancreatitis and APACHE Ⅱ score predict development of infected pancreatic necrosis[J]. Dig Dis Sci, 2015, 60(2): 537-542. DOI: 10.1007/s10620-014-3081-y.
    [62]
    JI L, LV JC, SONG ZF, et al. Risk factors of infected pancreatic necrosis secondary to severe acute pancreatitis[J]. Hepatobiliary Pancreat Dis Int, 2016, 15(4): 428-433. DOI: 10.1016/s1499-3872(15)60043-1.
    [63]
    CHEN HZ, JI L, LI L, et al. Early prediction of infected pancreatic necrosis secondary to necrotizing pancreatitis[J]. Medicine (Baltimore), 2017, 96(30): e7487. DOI: 10.1097/MD.0000000000007487.
    [64]
    CHEN Y, KE L, MENG L, et al. Endothelial markers are associated with pancreatic necrosis and overall prognosis in acute pancreatitis: A preliminary cohort study[J]. Pancreatology, 2017, 17(1): 45-50. DOI: 10.1016/j.pan.2016.12.005.
    [65]
    ZHANG Y, GUO F, LI S, et al. Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitis[J]. Sci Rep, 2017, 7(1): 8064. DOI: 10.1038/s41598-017-06618-w.
    [66]
    CAO X, WANG HM, DU H, et al. Early predictors of hyperlipidemic acute pancreatitis[J]. Exp Ther Med, 2018, 16(5): 4232-4238. DOI: 10.3892/etm.2018.6713.
    [67]
    NODA Y, GOSHIMA S, FUJIMOTO K, et al. Utility of the portal venous phase for diagnosing pancreatic necrosis in acute pancreatitis using the CT severity index[J]. Abdom Radiol (NY), 2018, 43(11): 3035-3042. DOI: 10.1007/s00261-018-1579-z.
    [68]
    ÜNAL Y, BARLAS AM. Role of increased immature granulocyte percentage in the early prediction of acute necrotizing pancreatitis[J]. Ulus Travma Acil Cerrahi Derg, 2019, 25(2): 177-182. DOI: 10.14744/tjtes.2019.70679.
    [69]
    WAN J, YANG X, HE W, et al. Serum D-dimer levels at admission for prediction of outcomes in acute pancreatitis[J]. BMC Gastroenterol, 2019, 19(1): 67. DOI: 10.1186/s12876-019-0989-x.
    [70]
    CAMPBELL C, WANG T, MCNAUGHTON AL, et al. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis[J]. J Viral Hepat, 2021, 28(3): 493-507. DOI: 10.1111/jvh.13452.
    [71]
    QIN SH, TANG YM, LI Q, et al. Clinical efficacy and mechanism of Chaishao Chengqi Decoction in the treatment of acute pancreatitis[J]. Hunan J Tradit Chin Med, 2022, 38(6): 197-201. DOI: 10.16808/j.cnki.issn1003-7705.2022.06.046.

    覃树辉, 唐友明, 黎锵, 等. 柴芍承气汤治疗急性胰腺炎的临床疗效及作用机制研究进展[J]. 湖南中医杂志, 2022, 38(6): 197-201. DOI: 10.16808/j.cnki.issn1003-7705.2022.06.046.
    [72]
    JIANG D, LUO BW, LIANG ZH, et al. A preliminary study on the data model construction for predicting pancreatic necrosis in acute pancreatitis[J]. J Guangxi Med Univ, 2022, 39(7): 1106-1111. DOI: 10.16190/j.cnki.45-1211/r.2022.07.013.

    姜丹, 罗博文, 梁志海, 等. 预测急性胰腺炎发生胰腺坏死的数据模型建立的初步研究[J]. 广西医科大学学报, 2022, 39(7): 1106-1111. DOI: 10.16190/j.cnki.45-1211/r.2022.07.013.
    [73]
    FANCZAL J, PALLAGI P, GÖRÖG M, et al. TRPM2-mediated extracellular Ca2+ entry promotes acinar cell necrosis in biliary acute pancreatitis[J]. J Physiol, 2020, 598(6): 1253-1270. DOI: 10.1113/JP279047.
    [74]
    HALLENSLEBEN ND, TIMMERHUIS HC, HOLLEMANS RA, et al. Optimal timing of cholecystectomy after necrotising biliary pancreatitis[J]. Gut, 2022, 71(5): 974-982. DOI: 10.1136/gutjnl-2021-324239.
    [75]
    YADAV D, LOWENFELS AB. The epidemiology of pancreatitis and pancreatic cancer[J]. Gastroenterology, 2013, 144(6): 1252-1261. DOI: 10.1053/j.gastro.2013.01.068.
    [76]
    YADAV D, PAPACHRISTOU GI, WHITCOMB DC. Alcohol-associated pancreatitis[J]. Gastroenterol Clin North Am, 2007, 36(2): 219-238, vii. DOI: 10.1016/j.gtc.2007.03.005.
    [77]
    PANDOL SJ, RARATY M. Pathobiology of alcoholic pancreatitis[J]. Pancreatology, 2007, 7(2-3): 105-114. DOI: 10.1159/000104235.
    [78]
    CUTHBERTSON CM, CHRISTOPHI C. Disturbances of the microcirculation in acute pancreatitis[J]. Br J Surg, 2006, 93(5): 518-530. DOI: 10.1002/bjs.5316.
    [79]
    REBOURS V, BOUDAOUD L, VULLIERME MP, et al. Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia[J]. Am J Gastroenterol, 2012, 107(10): 1579-1585. DOI: 10.1038/ajg.2012.231.
    [80]
    EASLER J, MUDDANA V, FURLAN A, et al. Portosplenomesenteric venous thrombosis in patients with acute pancreatitis is associated with pancreatic necrosis and usually has a benign course[J]. Clin Gastroenterol Hepatol, 2014, 12(5): 854-862. DOI: 10.1016/j.cgh.2013.09.068.
    [81]
    SCHEPERS NJ, BAKKER OJ, BESSELINK MG, et al. Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis[J]. Gut, 2019, 68(6): 1044-1051. DOI: 10.1136/gutjnl-2017-314657.
    [82]
    MORAN RA, GARCÍA-RAYADO G, DE LA IGLESIA-GARCÍA D, et al. Influence of age, body mass index and comorbidity on major outcomes in acute pancreatitis, a prospective nation-wide multicentre study[J]. United European Gastroenterol J, 2018, 6(10): 1508-1518. DOI: 10.1177/2050640618798155.
    [83]
    COELHO A, MACHADO M, SAMPIETRE SN, et al. Local and systemic effects of aging on acute pancreatitis[J]. Pancreatology, 2019, 19(5): 638-645. DOI: 10.1016/j.pan.2019.06.005.
    [84]
    PAPACHRISTOU GI, MUDDANA V, YADAV D, et al. Comparison of BISAP, Ranson's, APACHE-Ⅱ, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis[J]. Am J Gastroenterol, 2010, 105(2): 435-441; quiz 442. DOI: 10.1038/ajg.2009.622.
    [85]
    KHATUA B, EL-KURDI B, SINGH VP. Obesity and pancreatitis[J]. Curr Opin Gastroenterol, 2017, 33(5): 374-382. DOI: 10.1097/MOG.0000000000000386.
    [86]
    NATU A, STEVENS T, KANG L, et al. Visceral adiposity predicts severity of acute pancreatitis[J]. Pancreas, 2017, 46(6): 776-781. DOI: 10.1097/MPA.0000000000000845.
    [87]
    CHEN L, HUANG Y, YU H, et al. The association of parameters of body composition and laboratory markers with the severity of hypertriglyceridemia-induced pancreatitis[J]. Lipids Health Dis, 2021, 20(1): 9. DOI: 10.1186/s12944-021-01443-7.
    [88]
    YAO Q, LIU P, PENG S, et al. Effects of immediate or early oral feeding on acute pancreatitis: A systematic review and meta-analysis[J]. Pancreatology, 2022, 22(2): 175-184. DOI: 10.1016/j.pan.2021.11.009.
    [89]
    KE L, MAO W, LI X, et al. The pancreatitis activity scoring system in predicting infection of pancreatic necrosis[J]. Am J Gastroenterol, 2018, 113(9): 1393-1394. DOI: 10.1038/s41395-018-0112-x.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (329) PDF downloads(28) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return